Journey Advisory Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,707
Closed -$215K 272
2025
Q4
$215K Sell
1,707
-3
-0.2% -$391 0.02% 252
2025
Q3
$250K Buy
1,710
+3
+0.2% +$453 0.02% 244
2025
Q2
$266K Hold
1,707
0.02% 252
2025
Q1
$281K Sell
1,707
-9
-0.5% -$1.5K 0.02% 244
2024
Q4
$297K Hold
1,716
0.04% 189
2024
Q3
$297K Hold
1,716
0.04% 189
2024
Q2
$297K Hold
1,716
0.04% 189
2024
Q1
$290K Buy
1,716
+85
+5% +$15.9K 0.04% 200
2023
Q4
$322K Buy
+1,631
New +$289K 0.04% 172
2023
Q3
Sell
-1,656
Closed -$285K 227
2023
Q2
$285K Buy
1,656
+143
+9% +$24.7K 0.04% 182
2023
Q1
$252K Buy
+1,513
New +$248K 0.04% 208

Other funds holding ZTS

Journey Advisory Group's ZTS Position: Q1 2026 in Review

Journey Advisory Group sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 1,707 shares — an estimated $215K sold.

Journey Advisory Group first reported a position in ZTS in Q1 2023 and held it in 11 quarters. The position peaked at $322K in Q4 2023. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Journey Advisory Group reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Journey Advisory Group sold 1,707 Zoetis shares in Q1 2026, an estimated $215K.
  • Journey Advisory Group first reported a position in Zoetis in Q1 2023 and held it in 11 quarters.
  • Journey Advisory Group's Zoetis position peaked at $322K in Q4 2023.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Journey Advisory Group's 13F filing for Q1 2026, filed 5 May 2026.